DI
ARCT icon

DFPG Investments’s Arcturus Therapeutics ARCT Stock Holding History

DFPG Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89,004
Closed -$5.75M – 161
2020
Q4 		$5.75M Sell
89,004
-94,799
-52% -$6.42M 2.64% 9
2020
Q3 		$9.36M Sell
183,803
-20,870
-10% -$1.04M 5% 2
2020
Q2 		$10.2M Sell
204,673
-112,111
-35% -$3.86M 6.19% 2
2020
Q1 		$5.7M Sell
316,784
-139,606
-31% -$1.79M 4.25% 3
2019
Q4 		$5.54M Sell
456,390
-4,060
-0.9% -$42.5K 3.62% 4
2019
Q3 		$4.8M Buy
+460,450
New +$4.98M 3.97% 2

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFPG Investments's ARCT Position: Q1 2021 in Review

DFPG Investments sold out of Arcturus Therapeutics (ARCT) in Q1 2021, closing a stake of 89,004 shares — an estimated $5.75M sold.

DFPG Investments first reported a position in ARCT in Q3 2019 and held it in 6 quarters. The position peaked at $10.2M in Q2 2020. 162 funds tracked by Wall St. Rank hold ARCT as of Q1 2021.

  • DFPG Investments reported no remaining Arcturus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • DFPG Investments sold 89,004 Arcturus Therapeutics shares in Q1 2021, an estimated $5.75M.
  • DFPG Investments first reported a position in Arcturus Therapeutics in Q3 2019 and held it in 6 quarters.
  • DFPG Investments's Arcturus Therapeutics position peaked at $10.2M in Q2 2020.
  • 162 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2021.

Based on DFPG Investments's 13F filing for Q1 2021, filed 14 Apr 2021.